Is NICE's Cost Effectiveness Threshold Too High?

Armen Hareyan's picture

Is NICE's cost effectiveness threshold too generous, ask experts in this week's BMJ?

The National Institute for Health and Clinical Excellence (NICE) is an independent body that decides which drugs should be available on the NHS in England and Wales. Since its inception in 1999, NICE has adopted a cost effectiveness threshold range of

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.